Other
Phathom Pharmaceuticals
Total Trials
2
Recruiting
0
Active
2
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 2 trials
Late-Stage Pipeline
100%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 4
2(100.0%)
2Total
Phase 4(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (2)
Showing 2 of 2 trials
NCT07224048Phase 4Active Not Recruiting
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2
Role: collaborator
NCT07224035Phase 4Active Not Recruiting
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1
Role: collaborator
All 2 trials loaded